Nanjing Pharmaceutical Company Limited (600713) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Nanjing Pharmaceutical Company Limited Company Snapshot

Business Description:

Nanjing Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. Nanjing Pharmaceutical Company Limited is principally engaged in manufacture and distribution of Chinese medicines and western drugs. The Company operates its businesses primarily through pharmaceutical distribution, which involves in operation of regular chain drug stores, delivery of pharmaceuticals, supply chain management and logistics services, among others; pharmaceutical production, which offers Chinese patent medicines, tablets, capsules, granules, solvent and bulk drugs, among others, as well as asset management business, which includes credit guarantee, international trading, hotel services and information services. The Company operates its businesses primarily in domestic market. In our complete report available for purchase the company is compared to: Shanghai Pharmaceutical Company Limited, Chuo Bussan Corporation and KYORIN Holdings, Incorporation.

Nanjing Pharmaceutical Company Limited

Stock Data:

Recent Stock Performance:

Current Price (2/10/2012): 4.60
(Figures in Chinese Renmimbi)

1 Week	14.7%	13 Weeks	17.0%

4 Weeks	-16.5%	52 Weeks	-20.7%

Nanjing Pharmaceutical Company Limited Key Data:

Ticker:	600713	Country:	CHINA

Exchanges:	SHG	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	15,337,627,000 (Year Ending Jan 2011).	Employees:	7,171

Currency:	Chinese Renmimbi	Market Cap:	3,190,471,128

Fiscal Yr Ends:	December	Shares Outstanding:	693,580,680

Share Type:	A Gu	Closely Held Shares:	N/A

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.